Physician profile
Roger J Bindra
NPI 1417082751
$1,175.00
in general payments reported to CMS, 2019-2025
17 companies · $340 in 2025
The $340 reported for 2025 was more than what 86% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $48.53 · 2021: $91.48 · 2022: $113 · 2023: $302 · 2024: $107 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $180.37 | 2019-2025 | |
| Sanofi Pasteur INC. | $165.67 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $137.87 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $118.13 | 2019-2025 | Gardasil 9, Enflonsia |
| Glaxosmithkline, LLC. | $109.67 | 2023 | Bexsero |
| Sanofi-Aventis U.S. LLC | $97.78 | 2023-2025 | |
| Sobi, INC | $68.74 | 2019-2020 | |
| Cranial Technologies, INC | $66.21 | 2019-2023 | Doc Band |
| Alk-Abello, INC | $37.11 | 2025 | Neffy |
| Organon LLC | $32.48 | 2025 | |
| Biogen, INC. | $27.86 | 2023 | Spinraza |
| Kaleo, INC. | $27.23 | 2024 | Auvi-Q |
| Genentech USA, INC. | $25.76 | 2025 | Xolair |
| Phadia US INC. | $24.19 | 2024 | Immunocap |
| Ironshore Pharmaceuticals INC. | $23.68 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $20.49 | 2025 | Spinosad, Natroba |
| Seqirus USA INC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Bindra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.